Chantilly Biopharma LLC
Records under this name other than patents Chantilly Biopharma LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Chantilly Biopharma LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,165,512 | Dosage forms containing taste masked active agents Term ended Term ended Oct 30, 2018 · From the USPTO record | Term ended | Term ended Oct 30, 2018 | From the USPTO record |
| US 7,815,937 | Quick Dissolve Compositions and Tablets Based Thereon Lapsed on the fee record Ended Oct 19, 2018 · Medium confidence | Lapsed on the fee record | Ended Oct 19, 2018 | Medium confidence |
| US 6,090,830 | Controlled release compositions and methods for the treatment of hyperlipidemia Term ended Term ended Jul 20, 2018 · From the USPTO record | Term ended | Term ended Jul 20, 2018 | From the USPTO record |
| US 6,312,724 | Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof Term ended Term ended Apr 3, 2018 · From the USPTO record | Term ended | Term ended Apr 3, 2018 | From the USPTO record |
| US 6,013,280 | Immediate release dosage forms containing microspheres Term ended Term ended Oct 7, 2017 · From the USPTO record | Term ended | Term ended Oct 7, 2017 | From the USPTO record |
| US 6,383,516 | Sustained-Release Microgranules Containing Diltiazem as Active Principle Term ended Term ended Dec 23, 2016 · Medium confidence | Term ended | Term ended Dec 23, 2016 | Medium confidence |
| US 6,660,296 | Sustained-Release Microgranules Containing Diltiazem as Active Principle Term ended Term ended Dec 23, 2016 · Medium confidence | Term ended | Term ended Dec 23, 2016 | Medium confidence |
| US 6,391,338 | System for rendering substantially non-dissoluble bio-affecting agents bio-available Term ended Term ended Sep 7, 2015 · From the USPTO record | Term ended | Term ended Sep 7, 2015 | From the USPTO record |
| US 6,509,037 | Sustained Release Pharmaceutical Matrix Tablet of Pharmaceutically Acceptable Salts of Diclofenac and Process for Preparation Thereof Lapsed on the fee record Ended Jan 21, 2015 · Medium confidence | Lapsed on the fee record | Ended Jan 21, 2015 | Medium confidence |
| US 6,386,628 | Folding table and seating apparatus Lapsed on the fee record Ended May 14, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 14, 2014 | From the USPTO record |